单位:[1]Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu-city, Yamanashi, Japan[2]The University of Tokyo, Tokyo, Japan[3]Department of Oncology and Internal Medicine, National Taiwan University Hospital, National Taiwan University Cancer Center and Graduate Institute of Oncology, National Taiwan University, Taipei, Taiwan[4]Hepato-Biliary-Pancreatic Surgery Division and Artificial Organ and Transplantation Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan[5]Department of Gastroenterology and Hepatology, Kindai University School of Medicine, Osaka-Sayama, Osaka, Japan[6]Department of Radiology and Institute of Radiation Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea[7]Beijing Key Laboratory of Translational Medicine on Cirrhosis, National Clinical Research Center for Digestive Diseases, Liver Research Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China临床科室国家中心肝病分中心首都医科大学附属北京友谊医院[8]Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan[9]Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea[10]Department of Hepatology, Postgraduate Institute of Medical Education and Research, Chandigarh, India[11]Department of Gastroenterology, Juntendo University, Tokyo, Japan[12]Department of Medicine, Aga Khan University and Hospital, Karachi, Pakistan[13]Department of Hepatology, Cardinal Santos Medical Center, Manila, Philippines[14]Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan中山大学附属第二医院[15]Department of Gastroenterology and Nephrology, Graduate School of Medicine, Chiba University, Chiba, Japan[16]Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan[17]Digestive Disease and GI Oncology Center, Medistra Hospital, University of Indonesia, Jakarta, Indonesia[18]Department of Internal Medicine, Cipto Mangunkusumo Hospital, University of Indonesia, Jakarta, Indonesia[19]Third Department of Internal Medicine, Teikyo University School of Medicine, Chiba, Japan[20]Department of Gastroenterology, Ankara University School of Medicine, Ankara, Turkey[21]Department of Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India
There is great geographical variation in the distribution of hepatocellular carcinoma (HCC), with the majority of all cases worldwide found in the Asia-Pacific region, where HCC is one of the leading public health problems. Since the "Toward Revision of the Asian Pacific Association for the Study of the Liver (APASL) HCC Guidelines" meeting held at the 25th annual conference of the APASL in Tokyo, the newest guidelines for the treatment of HCC published by the APASL has been discussed. This latest guidelines recommend evidence-based management of HCC and are considered suitable for universal use in the Asia-Pacific region, which has a diversity of medical environments.
基金:
BayerBayer AG; Boehringer IngelheimBoehringer Ingelheim; Bristol-Myers SquibbBristol-Myers Squibb; OtsukaOtsuka Pharmaceutical; AstellasAstellas Pharmaceuticals; Gilead SciencesGilead Sciences; Chugai; Mitsubishi TanabeMitsubishi Tanabe Pharma Corporation; Kyorin; Merck Sharp and DohmeMerck & Company; Dainippon SumitomoDainippon Sumitomo Pharma Co., Ltd.; Vertex PharmaceuticalsVertex Pharmaceuticals; TakedaTakeda Pharmaceutical Company Ltd; Merck SeronoMerck & Company; Zeria; NovartisNovartis; EisaiEisai Co Ltd; ONXEO; Ono Pharmaceutical; Ajinomoto; AbbVieAbbVie; Kowa; Taiho; RocheRoche Holding; Grants-in-Aid for Scientific ResearchMinistry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI) [16K10363] Funding Source: KAKEN
第一作者单位:[1]Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu-city, Yamanashi, Japan[2]The University of Tokyo, Tokyo, Japan
通讯作者:
通讯机构:[1]Department of Gastroenterology, Yamanashi Prefectural Central Hospital, Kofu-city, Yamanashi, Japan[2]The University of Tokyo, Tokyo, Japan
推荐引用方式(GB/T 7714):
Masao Omata,Ann-Lii Cheng,Norihiro Kokudo,et al.Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update[J].HEPATOLOGY INTERNATIONAL.2017,11(4):317-370.doi:10.1007/s12072-017-9799-9.
APA:
Masao Omata,Ann-Lii Cheng,Norihiro Kokudo,Masatoshi Kudo,Jeong Min Lee...&Shiv Kumar Sarin.(2017).Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.HEPATOLOGY INTERNATIONAL,11,(4)
MLA:
Masao Omata,et al."Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update".HEPATOLOGY INTERNATIONAL 11..4(2017):317-370